FdaApplication
BLA 125819
Identifiers
- fda_app_no: BLA125819
Properties
| Property | Value |
|---|---|
| applicant_name | GlaxoSmithKline Biologicals |
| application_type | BLA |
| approval_date | 2025-02-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PENMENVY | — | 25UG/0.5ML | Injection |
1 product